Presentation delivered at Forum on Innovations and Actions Against Non-Communicable Diseases (IAAN), Asian Development Bank, Manila, Philippines, 18 July 2018
Women in Nuclear, IAEA Programme of Action for Cancer TherapyAnja Nitzsche-Bell
Introduction to the IAEA Programme of Action for Cancer Therapy (PACT): Maximizing Investments in Radiation Medicine, presented at 23rd WiN Global Annual Conference -
Women in Nuclear Meet Atoms for Peace, Vienna, 2015
Order & Unity: UT Southwestern Case Study on Imaging AppropriatenessMick Brown
On a sunny Saturday in May 2017, nearly 400 primary care physicians, specialists, nurse practitioners, physician assistants, technologists, and nurses crowded into the Gaylord Texan Convention Center in Grapevine, Tex. Despite the beautiful spring weather, participants eagerly gathered indoors to attend the second “The Right Scan from Head to Toe” radiology utilization conference, where they would learn about and discuss best practices for enhancing performance- based metrics when ordering radiology exams.
Women in Nuclear, IAEA Programme of Action for Cancer TherapyAnja Nitzsche-Bell
Introduction to the IAEA Programme of Action for Cancer Therapy (PACT): Maximizing Investments in Radiation Medicine, presented at 23rd WiN Global Annual Conference -
Women in Nuclear Meet Atoms for Peace, Vienna, 2015
Order & Unity: UT Southwestern Case Study on Imaging AppropriatenessMick Brown
On a sunny Saturday in May 2017, nearly 400 primary care physicians, specialists, nurse practitioners, physician assistants, technologists, and nurses crowded into the Gaylord Texan Convention Center in Grapevine, Tex. Despite the beautiful spring weather, participants eagerly gathered indoors to attend the second “The Right Scan from Head to Toe” radiology utilization conference, where they would learn about and discuss best practices for enhancing performance- based metrics when ordering radiology exams.
Patient-Generated Data for Cancer Treatment and ManagementTommy Snitz
Research poster created by myself and Matthew Villarreal while we were students of The University of Texas at Austin's Health Informatics and Health IT Program.
Looks into the benefits and challenges of using patient-generated data in cancer treatment and management
Data sharing drivers in precision oncology, biomedical research, and healthcare. Accelerating discovery, innovation, providing credit for all stakeholders - patients, researchers, care providers, payers.
Ethical, Legal, and Social Implications of ELSI Learning Health Systems 2017 Conference, University of Michigan. Learning from the experience and outcomes of every cancer patient
iHT² Health IT Summit San Francisco – Case Study “Building A Sustainable Telemedicine Cooperative: The Arizona State-Wide Telemedicine Program” with Ronald Weinstein, M.D., Director, Arizona Telemedicine Program
Don't miss our upcoming webinars. Subscribe today!
Join Alies, a patient partner, and Ambreen, a patient-oriented researcher as they talk about Equity-Mobilizing Partnerships in Community (EMPaCT) a patient partnership model co-designed to center the voices of diverse community members and build capacity for equitable patient-oriented partnerships. In this webinar, Alies and Ambreen describe how they engaged multiple stakeholders including institutional leadership, funding bodies, knowledge users and most importantly, the patient community to identify common goals and intersecting opportunities and channelled them to create clear health-equity oriented pathways to change.
View the YouTube video: https://youtu.be/O2FKVsO0x_E
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
UCSF Informatics Day 2014 - Keith R. Yamamoto, "Precision Medicine"CTSI at UCSF
Keith R. Yamamoto, PhD — Opening Remarks – Precision Medicine
Vice Chancellor for Research
Executive Vice Dean of the School of Medicine
Professor of Cellular and Molecular Pharmacology
UCSF
SROA Presentation - Clinical Results of a Medical Error Reduction/Compliance ...edbkline
Clinical results from application of paper-based medical error reduction/compliance program vs software-based MERP program implenented at 30 free-standing radiation oncology centers.
Support & information for radiotherapy patients: how can social media help?KimMeeking
Slides from my presentation looking at social media for patient benefit and also for healthcare professionals in the field of cancer and radiation therapy.
Presented at the UK Radiological and Radiation Oncology Congress (UKRCO), Liverpool, July 2nd 2018
US Federal Cancer Moonshot- One Year LaterJerry Lee
Presentation from former Cancer Moonshot Data and Technology Track Co-chairs Jerry S.H. Lee, PhD (NCI, former OVP) and Dimitri Kusnezov, PhD (DOE) to update on efforts that will help realize the Data/Tech Track's vision of a national learning healthcare system for cancer. These include NCI/DOE pilots, DOE/VA pilot, NCI GDC, DoD/VA/NCI APOLLO, NCI/GSK ATOM, and BloodPAC.
Presentation at PORTAGE (Paediatric Oncology Roundtable to Transform Access to Global Essentials) Inaugeral Meeting, hosted by Friends of Cancer Patients, Childhood Cancer International and International Society of Paediatric Oncology, 16-18 January 2018, Sharjah, UAE
Ariane Weinman presents at ESMO 2021 on how the integration of a specific section on rare cancers into NCCPs can support patients' from diagnosis to treatment
Patient-Generated Data for Cancer Treatment and ManagementTommy Snitz
Research poster created by myself and Matthew Villarreal while we were students of The University of Texas at Austin's Health Informatics and Health IT Program.
Looks into the benefits and challenges of using patient-generated data in cancer treatment and management
Data sharing drivers in precision oncology, biomedical research, and healthcare. Accelerating discovery, innovation, providing credit for all stakeholders - patients, researchers, care providers, payers.
Ethical, Legal, and Social Implications of ELSI Learning Health Systems 2017 Conference, University of Michigan. Learning from the experience and outcomes of every cancer patient
iHT² Health IT Summit San Francisco – Case Study “Building A Sustainable Telemedicine Cooperative: The Arizona State-Wide Telemedicine Program” with Ronald Weinstein, M.D., Director, Arizona Telemedicine Program
Don't miss our upcoming webinars. Subscribe today!
Join Alies, a patient partner, and Ambreen, a patient-oriented researcher as they talk about Equity-Mobilizing Partnerships in Community (EMPaCT) a patient partnership model co-designed to center the voices of diverse community members and build capacity for equitable patient-oriented partnerships. In this webinar, Alies and Ambreen describe how they engaged multiple stakeholders including institutional leadership, funding bodies, knowledge users and most importantly, the patient community to identify common goals and intersecting opportunities and channelled them to create clear health-equity oriented pathways to change.
View the YouTube video: https://youtu.be/O2FKVsO0x_E
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
UCSF Informatics Day 2014 - Keith R. Yamamoto, "Precision Medicine"CTSI at UCSF
Keith R. Yamamoto, PhD — Opening Remarks – Precision Medicine
Vice Chancellor for Research
Executive Vice Dean of the School of Medicine
Professor of Cellular and Molecular Pharmacology
UCSF
SROA Presentation - Clinical Results of a Medical Error Reduction/Compliance ...edbkline
Clinical results from application of paper-based medical error reduction/compliance program vs software-based MERP program implenented at 30 free-standing radiation oncology centers.
Support & information for radiotherapy patients: how can social media help?KimMeeking
Slides from my presentation looking at social media for patient benefit and also for healthcare professionals in the field of cancer and radiation therapy.
Presented at the UK Radiological and Radiation Oncology Congress (UKRCO), Liverpool, July 2nd 2018
US Federal Cancer Moonshot- One Year LaterJerry Lee
Presentation from former Cancer Moonshot Data and Technology Track Co-chairs Jerry S.H. Lee, PhD (NCI, former OVP) and Dimitri Kusnezov, PhD (DOE) to update on efforts that will help realize the Data/Tech Track's vision of a national learning healthcare system for cancer. These include NCI/DOE pilots, DOE/VA pilot, NCI GDC, DoD/VA/NCI APOLLO, NCI/GSK ATOM, and BloodPAC.
Presentation at PORTAGE (Paediatric Oncology Roundtable to Transform Access to Global Essentials) Inaugeral Meeting, hosted by Friends of Cancer Patients, Childhood Cancer International and International Society of Paediatric Oncology, 16-18 January 2018, Sharjah, UAE
Ariane Weinman presents at ESMO 2021 on how the integration of a specific section on rare cancers into NCCPs can support patients' from diagnosis to treatment
ndia is one of the developing countries who have national cancer control programme (NCCP). We started way back in 1975 and the plan has been revised three times. The first revision was in 1984, second one in 1991 and third one 2004.
Teleradiology is a branch of telemedicine in which telecommunication systems are used to transmit radiological images from one location to another. Interpretation of all noninvasive imaging studies, such as digitized x-rays, CT, MRI, ultrasound, and nuclear medicine studies, can be carried out in such a manner.
The first steps in teleradiology date back to 1929 when a medical image was transmitted via telegraph to a distant location
This presentation was presented by Dr. Abdul Nasir Qayyumi - Medical Director for CTTC-Medical Department. This presentation was presented in MoPH to support MoPH's priority of Cancer Screening and Treatment Center to be established in Afghanistan. Presented at 3:00pm,on Sunday, 23rd Dec 2012. www.cttc-af.org
The Asian Fund for Cancer Research, Ltd. (AFCR) is a non-profit organization committed to curing cancers that have significant impacts on Asian populations. Headquartered in Hong Kong, AFCR is uniquely positioned to implement in Asia the newest cancer research discoveries and technologies from around the world, investigate the distinct causes of cancer in Asian populations through innovative genetic and molecular research, and develop more effective therapies tailored to Asian cancer patients. AFCR is dedicated to bridging the scientific and educational gaps in cancer research and cancer prevention between Asian countries and the rest of the world through promoting, coordinating and funding international collaboration in cancer research and public education. We are fully devoted to reducing the incidence and increasing the survival rate of cancers in Asia. We encourage you to visit our website for more information about cancer prevention tips and our programs. http://afcr.org.hk/en
Similar to Cancer in Asia and Role of IAEA in Offering Support to Member States (20)
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Cancer in Asia and Role of IAEA in Offering Support to Member States
1. Situation of Cancer in Asia and the Role of
the IAEA in Supporting Cancer Control in
Low and Middle Income Countries
Anja Nitzsche
Head of Resource Mobilisation
IAEA, Programme of Action for Cancer Therapy
Forum on Innovations and Actions Against Non-Communicable
Diseases (IAAN), Asian Development Bank
Investing on the NCD Best Buys -Cancer Parallel Workshop
Manila, 18 July 2018
2. The Agency shall seek to accelerate and enlarge the
contribution of atomic energy to peace, health and
prosperity throughout the world.
Article II, IAEA Statute
3. The unique role of the IAEA
in comprehensive cancer control
EARLY
DETECTION
DIAGNOSIS TREATMENT
PALLIATIVE
CARE
PREVENTION
RADIATION
MEDICINE FOR
CANCER
MANAGEMENT
SURVEILLANCE
DIAGNOSTIC
IMAGING
NUCLEAR
MEDICINE
RADIOTHERAPY
3
4. Areas of support
Capacity building for
sustainable impact
Transferring science into practiceMaking technology available to
address development challenges
Resource mobilisation for
cancer control priorities
Quality assurance for
protection of patients
and health workers
5. A growing global health & development issue:
Asia and the Pacific
People developing cancer
in Asia & the Pacific
Source: GLOBOCAN 2012
6. A growing global health & development issue:
Asia and the Pacific
Annual cancer deaths in
Asia & the Pacific
Source: GLOBOCAN 2012
7. Inequity in Access to Cancer Care
(Example of radiotherapy)
25 countries with
radiotherapy
coverage below
50%
12 countries
without
appropriate
radiotherapy
services
Nearly 3,900
radiotherapy
machines needed
Source: GLOBOCAN 2012, IAEA 2016
9. AFRICA
€90 million
EUROPE
€76 million
LATIN AMERICA
€75 million
ASIA and the
PACIFIC
€68 million
INTERREGIONAL
€10 million
TOTAL EXPENDITURE
€319 million
IAEA Expenditure on Cancer-related Projects
(1980-2017)
10. IAEA support to Member States: 2017
Training and expert missions
• 475 fellowships and scientific visits in 2017
– Prevention and control of cancer, radiation oncology in
cancer management, nuclear medicine and diagnostic
imaging, and safe provision of radiation services.
Ongoing support activities
• Over 200 active projects for cancer and diagnosis
• Support to the national cancer projects
– dosimetry, radiopharmaceuticals, nuclear medicine,
cancer research (inc. paediatric cancer and nutrition of
cancer patients [planned]).
• Assessment and policy support
11. imPACT: Assessing national cancer control capacities
92 imPACT missions since 2005
2018 (to July): Afghanistan
Indonesia
Ukraine
12. Regional highlights – Asia and Pacific
• 137 medical professionals from 17 countries over 5 years trained
on 3D radiotherapy and the establishment of comprehensive
quality assurance programmes.
• Nuclear medicine diagnostic imaging in Sri Lanka
• Distance Assisted Training programme for Nuclear Medicine
Professionals
• Developing national multi-disciplinary cancer control capacities in
countries including Sri Lanka and Vietnam
• Mongolia Radiation oncology and medical physics infrastructure
and services assessed, radiotherapy treatment planning system
upgraded and equipment provided
• Pakistan A centre’s facilities from 2D to 3D conformal
radiotherapy upgraded.
• Cambodia Supporting establishment of first National Cancer
Centre
14. IAEA partnership with OIC & IsDB
• 2012: High-level seminar with OIC and IsDB in the Kingdom of
Saudi Arabia
• 2013: Consultative cooperation meeting with IAEA, OIC, IsDB
and common Member States in Vienna
• 2016: Istanbul Declaration, Special Session of the First Ladies’
Leadership in Cancer Control held during the 13th OIC Summit
in Turkey
• Signature of Practical Arrangement: IAEA, OIC, IsDB to support
MS in fundraising efforts and provide expert assistance to
address the growing cancer burden
• 2017: Meeting to Review Funding Gaps and Mobilize Resources
for the Implementation of Priority Interventions in National
Cancer Control Programmes of Common MS, Sudan
US$ 248 m grants and loans from IsDB to
IAEA Member States, since 2013.